David Taylor

“I think we’ve all gotten in habits of cleaning. We’ve got in the habit of the home being a bigger part of our life,” said Procter & Gamble Chairman and CEO David Taylor in an interview with CNBC. “In many ways, these habits will likely sustain for… an extended period of time post-pandemic, and that bodes well for many of the categories we compete in.”

The company, which has one of the strongest portfolios of consumer goods, including cleaning and beauty brands like Mr Clean and Fairy, was tipped to be among those that stood to gain from COVID-19. And while the initial rush for cleaning products seems to have ceased, the CEO believes that the effects on consumer behaviour will be long lasting.

“I think consumers recognise there’s still a lot of variability ahead in what could happen so they’re going to maintain a little more than they did pre-pandemic,” he said.

Mr Taylor continued to say that he foresees a continued focus on cleaning and hygiene, and while CNBC reports that investors are unsure of the longevity of COVID-related sales boosts as economic activity resumes and the virus threat alleviates, the CEO believes “health, cleaning and hygiene is going to remain strong post-pandemic.”

Featured Image:

Procter & Gamble Chairman and CEO David Taylor

Related

norman aquilina farsons

Farsons CEO on Vision 2050: ‘We need to feel a sense of ownership – from vision talk to mission mode’

24 November 2025
by Sam Vassallo

Norman Aquilina gives his take on the Government's longterm vision.

Malta’s biggest Airbnb operator: ‘Reform is needed, but not at the cost of a functioning market’

24 November 2025
by Sam Vassallo

Matthew Zammit from 360 Group thinks that some regulatory proposals are missing the mark.

G4S Malta enters new chapter as Securital

24 November 2025
by MaltaCEOs

G4S Malta is now Securital – a fresh identity that strengthens its local roots while carrying forward the same leadership, ...

MeDirect Bank announces three senior appointments

21 November 2025
by Nicole Zammit

The appointments remain subject to regulatory approval.